Professor Nobhojit Roy appointed Executive Director of The George Institute, India

Professor Nobhojit Roy has been appointed Executive Director of The George Institute for Global Health, India, succeeding Professor Vivekanand Jha, who led the Institute’s India office for 13 years.

Professor Roy is a surgeon, global health researcher, and health systems leader whose  experience spans research, clinical practice, policy and health system strengthening in India and internationally. His work has focused particularly on improving trauma outcomes and surgical care and strengthening healthcare delivery in resource-constrained settings.

He spent two decades at Bhabha Atomic Research Centre Hospital and Homi Bhabha National Institute in Mumbai, including as Professor and Chief of Surgical Services. He subsequently served as National Advisor for Public Health Planning and Evidence at the National Health Systems Resource Centre, Ministry of Health and Family Welfare, Government of India, and held senior health systems and knowledge partnership roles with CARE India.

Professor Roy has also served as Technical Officer for Surgery and Anaesthesia at the World Health Organization headquarters in Geneva and as Southeast Asia Regional Health Hub Lead at Oxford Policy Management. Most recently, he was Professor of Surgery and Chair of the Centre for Leadership at the University of Global Health Equity in Rwanda.

He has also contributed to the Lancet Commission on Global Surgery and the Lancet Commission on NCDs and Injuries in the Poorest Billion.

Professor Roy already has strong links with The George Institute through his work in global surgery and trauma, including with the Institute's WHO Collaborating Centre for Emergency, Critical and Operative Care.

Professor Anushka Patel, CEO of The George Institute, said Professor Roy's breadth of experience would be a significant asset to the Institute.

“

Roy brings a rare combination of clinical, research, policy and health systems experience, together with a deep understanding of the health challenges facing communities in India and other resource-constrained settings.

His collaborative leadership and commitment to translating evidence into practice will be invaluable as we build on the achievements of our India office and shape the next phase of its contribution to better health.

By:

Professor Patel

“

It is an honour to lead The George Institute India and help shape its next phase of growth. I look forward to working with colleagues and partners to build on the Institute’s strengths, embrace new opportunities and deepen its impact in India and globally.

By:

Professor Roy

Professor Roy succeeds Professor Vivekanand Jha, who will remain at The George Institute as a Professorial Fellow in non-communicable diseases, with a focus on kidney diseases, environmental change and their medical and social determinants, including clinical trials. He will also continue contributing to training and capacity building at the Institute and beyond.

Professor Patel thanked Professor Jha for his leadership:

“

We thank Vivek for his outstanding leadership and contribution to The George Institute over the past 13 years. Under his leadership, The George Institute, India has grown in reach, capability and influence.

We are delighted that he will remain an important part of the Institute as a research leader, mentor and advocate for translating evidence into better health.

By:

Professor Patel

Professor Jha said:

“

It has been an immense privilege to lead The George Institute, India over the past 13 years and to work alongside colleagues and partners deeply committed to improving health through research. I am proud of what we have achieved together and thankful to everyone who has contributed to the Institute’s growth and impact. I look forward to continuing our research program on NCDs, kidney diseases and their determinants, and contributing to capacity strengthening.

I wish Professor Roy every success as he takes the Institute forward.

By:

Professor Jha

Professor Roy took up the role on September 14, 2026.